C07D 267/20
[b, f]-condensed
C07D267/20 ([b, f]-condensed) appears on 104 US grants and 57 published applications in this corpus.
Search patents in C07D- Granted patents
- 104
- Published applications
- 57
- Assignees
- 48
- Inventors
- 274
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 8 | 0 |
| 1995 | 10 | 0 |
| 1996 | 4 | 0 |
| 1997 | 7 | 0 |
| 1998 | 15 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 2 | 1 |
| 2006 | 0 | 6 |
| 2007 | 1 | 3 |
| 2008 | 1 | 4 |
| 2009 | 1 | 3 |
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 3 | 1 |
| 2013 | 2 | 0 |
| 2014 | 1 | 3 |
| 2015 | 2 | 3 |
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 4 |
| 2019 | 2 | 1 |
| 2020 | 2 | 3 |
| 2021 | 3 | 1 |
| 2022 | 0 | 2 |
| 2023 | 3 | 4 |
| 2024 | 1 | 2 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same7 Oct 2025US 12,435,047 B2Pontifica Universidad Catoclica de Chile
- HECT E3 ligase inhibitors and uses thereof2 Sep 2025US 12,403,144 B2Ieo - Istituto Europeo Di Oncologia S.R.L.
- MCL-1 inhibitors10 Dec 2024US 12,162,844 B2Gilead Sciences, Inc.
- Hepatitis b core protein modulators14 Nov 2023US 11,814,376 B2Assembly Biosciences, Inc.
- C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same16 May 2023US 11,649,218 B2Pontificia Universidad Catolica De Chile
- Slack-activating compounds and their medical use3 Sep 2026US 2026/0258003 A1
- Treatment methods16 Apr 2026US 2026/0102407 A1
- C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same6 Nov 2025US 2025/0340521 A1Pontificia Universidad Catolica De Chile
- Mcl-1 inhibitors15 May 2025US 2025/0154116 A1Gilead Sciences, Inc.
- Treatment methods15 Feb 2024US 2024/0050444 A1
Most cited
By later US patents
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996
- Tricyclic benzazepine vasopressin antagonists46US 5,849,735 AAmerican Cyanamid Company · 1998
- 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[(phenylsulfinyl-, and phenylsulfonyl)alkanoyl]hydrazides43US 4,704,386 AG. D. Searle & Co. · 1987
- 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use43US 5,354,747 AG. D. Searle & Co. · 1994
- Dibenzoxazepine N-carboxylic acid hydrazides and derivatives39US 3,989,719 AG. D. Searle & Co. · 1976